Penwest Fourth Quarter and Year End 2009 Financial Results Conference Call
February 23, 2010 10:01 ET
|
Penwest Pharmaceuticals Co.
PATTERSON, N.Y., Feb. 23, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Thursday, March 4, at 11:00 a.m. EST to review its financial results for...
Penwest Initiates Second Phase IIa Clinical Trial for A0001
February 09, 2010 08:00 ET
|
Penwest Pharmaceuticals Co.
PATTERSON, N.Y., Feb. 9, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has initiated a Phase IIa clinical trial for A0001 in patients with the A3243G...
Penwest Enters Into Fourth Research and Development Agreement With Otsuka Pharmaceutical
January 25, 2010 09:17 ET
|
Penwest Pharmaceuticals Co.
PATTERSON, N.Y., Jan. 25, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has signed its fourth research and development agreement with Otsuka Pharmaceutical...
Penwest Announces Initiation of Phase IIa Clinical Trial of A0001 in Patients With Friedreich's Ataxia
January 11, 2010 08:00 ET
|
Penwest Pharmaceuticals Co.
PATTERSON, N.Y., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it initiated a Phase IIa clinical trial for A0001 in December and that the screening...
Penwest Reports Third Quarter 2009 Financial Results
November 05, 2009 08:00 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., Nov. 5, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today reported its financial results for the third quarter of 2009. Compared with the third quarter of 2008,...
Penwest Third Quarter 2009 Financial Results Conference Call
October 30, 2009 13:46 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., Oct. 30, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Thursday, November 5, at 11:00 a.m. ET to review its financial results for...
Penwest Formulation Demonstrates Proof-of-Principal in Phase I Trial in Development Program With Otsuka Pharmaceutical
October 28, 2009 08:00 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., Oct. 28, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that its formulation of a product of Otsuka Pharmaceutical Co., Ltd. that Penwest had...
Penwest Named One of Connecticut's Fastest Growing Technology Companies
October 08, 2009 08:00 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., Oct. 8, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has been named an award winner in the Life Sciences category on the UHY LLP Tech Top...
Penwest to Present At Thomas Weisel Partners 2009 Healthcare Conference
September 03, 2009 09:00 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., Sept. 3, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Jennifer Good, President and Chief Executive Officer of Penwest, will be presenting at...
Penwest Reports Second Quarter 2009 Financial Results
August 07, 2009 08:00 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., Aug. 7, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today reported its financial results for the second quarter of 2009. Compared with the second quarter of...